ROLR stock jumps after High Roller signs Crypto.com deal for U.S. prediction markets
14 January 2026
2 mins read

ROLR stock jumps after High Roller signs Crypto.com deal for U.S. prediction markets

Las Vegas, Jan 14, 2026, 06:10 PST

  • High Roller inked a binding LOI with Crypto.com’s Derivatives North America division to launch U.S. event-based prediction markets
  • Companies aim to launch on HighRoller.com in Q1 2026, pending final agreements
  • In premarket trading, shares jumped roughly 17%

High Roller Technologies announced Wednesday it has inked a binding letter of intent with Crypto.com | Derivatives North America to roll out an event-based prediction markets product in the U.S. The Las Vegas online casino operator’s shares jumped 17.3% to $3.52 in premarket action. The company carries a market value near $30 million, per Investing.com data. Investing

The partnership arrives amid growing regulatory scrutiny of prediction markets—platforms where traders buy contracts tied to future event outcomes. On Tuesday, a federal judge barred Tennessee from blocking Kalshi, a competing operator, from offering sports event contracts in the state, according to a court order. Reuters

High Roller announced that Crypto.com’s Derivatives North America unit, CDNA, will provide “event contracts” to users via HighRoller.com through an exclusive partnership. These contracts are derivatives settled on whether a particular event happens, instead of tracking stock or commodity prices. The companies aim to roll out the product in the first quarter of 2026, though the agreement is still pending final sign-off. Globenewswire

“We’re excited to introduce High Roller to the U.S. through this strategic tie-up with Crypto.com,” said CEO Seth Young. Travis McGhee, Crypto.com’s global head of predictions, praised the deal, saying the firm is “thrilled to expand access to event contracts” via partnerships like this. Crypto.com noted that CDNA is registered with the U.S. Commodity Futures Trading Commission as both a designated contract market and a derivatives clearing organization — allowing it to list contracts and clear trades. Crypto

High Roller runs the online casino brands High Roller and Fruta, boasting over 6,000 games from more than 90 providers. The firm is listed on the NYSE as ROLR. Stocktitan

High Roller said the product would enable trading on outcomes spanning finance, entertainment, and sports. It referenced a third-party estimate suggesting a mature U.S. prediction market might surpass $1 trillion in annual trading volume.

But the deal isn’t set in stone. High Roller cautioned there’s no guarantee the parties will nail down definitive agreements. Neither company revealed the commercial terms or how they plan to divide the revenue.

Regulation remains a key wildcard. Though CDNA is registered with the CFTC, debates over whether certain sports event contracts amount to gambling have ignited battles at the state level, raising the possibility of delays, restrictions, or legal expenses.

High Roller’s deal would bring a trading product to its online casino lineup, relying on Crypto.com’s regulated derivatives platform to handle contract listing and clearing.

Under the LOI, Crypto.com will serve as the exclusive provider of prediction contracts throughout High Roller’s distribution network, the company announced.

Stock Market Today

  • Novavax jumps 11.9% on Cantor Fitzgerald upgrade; eyes on 2025 sales and Matrix-M potential
    January 14, 2026, 10:14 AM EST. Novavax NVAX jumped 11.9% in the last session, closing at $8.67 on stronger-than-average volume. The move followed reports that Cantor Fitzgerald reiterated an Overweight rating with a $18 target, more than double the current price. Cantor sees 2025 sales improving as Nuvaxovid gains momentum under Sanofi's commercial leadership, and views Novavax's Matrix-M vaccine platform as a long-term asset. The stock also climbed after a four-week run of about 17.8%. Analysts expect a quarterly loss of $0.66 per share (EPS = earnings per share) and revenue of $78.41 million, down 11.2% year over year. A higher or lower revision in earnings estimates often moves prices in the near term, and Novavax currently has a Zacks Rank #3 (Hold). Ocugen, in the same space, rose 7.3%.
GMA just posted new 40%-off deals — Wayfair, Macy’s and Amazon discounts in focus
Previous Story

GMA just posted new 40%-off deals — Wayfair, Macy’s and Amazon discounts in focus

Nvidia stock (NVDA) steadies as China blocks H200 chip imports, clouding U.S. export green light
Next Story

Nvidia stock (NVDA) steadies as China blocks H200 chip imports, clouding U.S. export green light

Go toTop